Roy S

475 total citations
21 papers, 340 citations indexed

About

Roy S is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roy S has authored 21 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roy S's work include Cancer Cells and Metastasis (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Cancer-related gene regulation (3 papers). Roy S is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Cancer-related gene regulation (3 papers). Roy S collaborates with scholars based in India, Italy and Singapore. Roy S's co-authors include Birendranath Banerjee, Roy S, Madhabananda Kar, Arka Saha, Yusuf Akhter, Amit Kumar Adhya, Amit Kumar, M. Prakash Hande, Shweta Thakur and Gianluca Gatto and has published in prestigious journals such as International Journal of Biological Macromolecules, Cancers and Oral Oncology.

In The Last Decade

Roy S

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy S India 10 224 103 77 41 27 21 340
Houyu Ju China 14 214 1.0× 162 1.6× 146 1.9× 57 1.4× 33 1.2× 28 415
Ana R. Raimondi Argentina 9 128 0.6× 82 0.8× 40 0.5× 40 1.0× 13 0.5× 16 253
Weimin Ding China 10 171 0.8× 100 1.0× 63 0.8× 52 1.3× 28 1.0× 25 307
Longlong Xie China 12 264 1.2× 145 1.4× 119 1.5× 33 0.8× 76 2.8× 27 465
Junxia Gu China 13 251 1.1× 74 0.7× 99 1.3× 35 0.9× 26 1.0× 35 392
Viola Schmiemann Germany 8 391 1.7× 86 0.8× 99 1.3× 62 1.5× 13 0.5× 10 454
Yukiko Ishibashi Japan 12 113 0.5× 58 0.6× 51 0.7× 18 0.4× 30 1.1× 29 332
Kristell Wanherdrick France 7 171 0.8× 58 0.6× 61 0.8× 24 0.6× 32 1.2× 8 275
Jadzia Tin-Tsen Chou Poland 6 157 0.7× 150 1.5× 74 1.0× 70 1.7× 16 0.6× 15 421
Xiaoli Ji China 8 166 0.7× 104 1.0× 103 1.3× 28 0.7× 10 0.4× 14 324

Countries citing papers authored by Roy S

Since Specialization
Citations

This map shows the geographic impact of Roy S's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy S with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy S more than expected).

Fields of papers citing papers by Roy S

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy S. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy S. The network helps show where Roy S may publish in the future.

Co-authorship network of co-authors of Roy S

This figure shows the co-authorship network connecting the top 25 collaborators of Roy S. A scholar is included among the top collaborators of Roy S based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy S. Roy S is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patra, R. N., et al.. (2025). Improving AAV Production Yield and Quality for Different Serotypes Using Distinct Processing Methods. ACS Omega. 10(22). 22657–22670. 1 indexed citations
2.
S, Roy, et al.. (2022). Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies. Frontiers in Medicine. 9. 906482–906482. 11 indexed citations
3.
S, Roy, Madhabananda Kar, Roy S, et al.. (2020). Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells. International Journal of Biological Macromolecules. 149. 501–512. 34 indexed citations
4.
S, Roy, Audrey Laroche‐Clary, Stéphanie Verbeke, Marie‐Alix Derieppe, & Antoîne Italiano. (2020). MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers. 12(8). 2253–2253. 11 indexed citations
5.
S, Roy, Roy S, Madhabananda Kar, et al.. (2019). Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 846. 503084–503084. 24 indexed citations
6.
S, Roy, et al.. (2019). KLF4 expression in the surgical cut margin is associated with disease relapse of oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 128(2). 154–165. 9 indexed citations
7.
Saha, Arka, Roy S, Madhabananda Kar, et al.. (2018). Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC. Stem Cell Reviews and Reports. 14(6). 871–887. 12 indexed citations
8.
S, Roy, Roy S, Madhabananda Kar, et al.. (2018). p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer. Oncogenesis. 7(7). 53–53. 18 indexed citations
9.
S, Roy, et al.. (2018). The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 836(Pt A). 89–97. 32 indexed citations
10.
S, Roy, et al.. (2018). Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. Journal of Oral Pathology and Medicine. 47(5). 492–501. 31 indexed citations
11.
S, Roy, et al.. (2017). Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma. Cellular Oncology. 41(2). 185–200. 37 indexed citations
12.
S, Roy, Madhabananda Kar, Arka Saha, et al.. (2017). Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma. Oral Oncology. 73. 27–35. 73 indexed citations
13.
Saha, Arka, et al.. (2017). Role of TRF2 in efficient DNA repair, spheroid formation and Cancer Stem Cell maintenance. 2. 71–79. 8 indexed citations
14.
Saha, Arka, et al.. (2014). Method of detecting new cancer stem cell-like enrichment in development front assay (DFA).. PubMed. 9(4). 235–42. 7 indexed citations
15.
Saha, Arka, et al.. (2014). HCT116 colonospheres shows elevated expression of hTERT and β-catenin protein - a short report.. PubMed. 9(4). 243–51. 9 indexed citations
16.
S, Roy, et al.. (2007). Comprehensive health care including sexual and reproductive health of adolescents and youths is of vital importance to the nation.. 30(4). 6 indexed citations
17.
Op, Ghai, et al.. (1981). Immuno-modulation: a therapeutic approach in Indian childhood cirrhosis.. PubMed. 18(4). 247–52. 3 indexed citations
18.
S, Roy, et al.. (1979). Whole-organ sections of the larynx and hypopharynx.. PubMed. 58(4). 173–80. 1 indexed citations
19.
S, Roy. (1977). An ultrastructural study of medulloblastoma.. PubMed. 25(4). 226–9. 7 indexed citations
20.
S, Roy, et al.. (1973). Salt losing nephritis in the prune belly syndrome.. PubMed. 66(11). 1045–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026